Pharmacotherapy of age-related macular degeneration (AMD)

ISSN： 2195-2175

Source： PHARMAKON, Vol.3, Iss.5, 2015-09, pp. : 388-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey Mrejen Sarah Gallego-Pinazo Roberto

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 535-541

Bentham Science Publishers

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite